Received Sep 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | — | OT |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | — | OT |
63 year old male vaccinated with Nonavalent HPV vaccine; Literature Article. This literature report received from the authors above and refers to a(n) 60-year-old male patient. The patient's medical history included Solid organ transplant at his 55 years old. The patient's concurrent conditions included chronic immunosuppression. Concomitant therapies were not reported. On an unknown date (reported as 4 years after the transplant), the patient started therapy with Human Papillomavirus 9-valent Vaccine, Recombinant (manufacturer unknown), Injection, a 2 doses scheme (administration route, lot # and expiration date were not reported) for prophylaxis (product administered to patient of inappropriate age). This is one of 4 same literature reports. A copy of the published article is attached as further documentation of the patient's experience.
Immunosuppression
Medical History/Concurrent Conditions: Solid organ transplant